Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers

Authors

Laura W. Goff, Vanderbilt-Ingram Cancer Center, Nashville
Nilay Thakkar, University of Kentucky
Liping Du, Vanderbilt-Ingram Cancer Center, Nashville
Emily Chan, Vanderbilt-Ingram Cancer Center, Nashville
Benjamin R. Tan, Washington University School of Medicine in St. Louis
Dana B. Cardin, Vanderbilt-Ingram Cancer Center, Nashville
Howard L. McLeod, Moffit Cancer Center, Tampa
Jordan D. Berlin, Vanderbilt-Ingram Cancer Center, Nashville
Barbara Zehnbauer, Centers for Disease Control and Prevention, Atlanta
Chloe Fournier, Washington University School of Medicine in St. Louis
Joel Picus, Washington University School of Medicine in St. Louis
Andrea Wang-Gillam, Washington University School of Medicine in St. Louis
Wooin Lee, University of Kentucky
A. Craig Lockhart, Washington University School of Medicine in St. LouisFollow

Journal

PLoS One

Publication Date

2014

Volume

9

Issue

9

Inclusive Pages

e107424

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0107424

Rights and Permissions

Goff LW, Thakkar N, Du L, Chan E, Tan BR, et al. (2014) Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers. PLoS ONE 9(9): e107424. doi: 10.1371/journal.pone.0107424

Recommended Citation

Goff, Laura W.; Thakkar, Nilay; Du, Liping; Chan, Emily; Tan, Benjamin R.; Cardin, Dana B.; McLeod, Howard L.; Berlin, Jordan D.; Zehnbauer, Barbara; Fournier, Chloe; Picus, Joel; Wang-Gillam, Andrea; Lee, Wooin; and Lockhart, A. Craig, "Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers." PLoS One. 9, 9. e107424. (2014).
https://digitalcommons.wustl.edu/open_access_pubs/3403